Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02920-2Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Karina A. Miller Seamus Degan Yanqing Wang Joseph Cohen Sheng Yu Ku David W. Goodrich Irwin H. Gelman Source Type: research
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02914-0PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Shailender S. Chauhan Andrea L. Casillas Andres D. Vizzerra Hope Liou Amber N. Clements Caitlyn E. Flores Christopher T. Prevost David F. Kashatus Ashley J. Snider Justin M. Snider Noel A. Warfel Source Type: research
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02910-4RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Xiao Yu Pengfei Zhao Qingyu Luo Xiaowei Wu Yating Wang Yabing Nan Shi Liu Wenyan Gao Bin Li Zhihua Liu Zhumei Cui Source Type: research
From odor to oncology: non-canonical odorant receptors in cancer
Oncogene, Published online: 12 December 2023; doi:10.1038/s41388-023-02908-yFrom odor to oncology: non-canonical odorant receptors in cancer (Source: Oncogene)
Source: Oncogene - December 12, 2023 Category: Cancer & Oncology Authors: Sung Jin Park Paul L. Greer Namgyu Lee Source Type: research
The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention
Oncogene, Published online: 11 December 2023; doi:10.1038/s41388-023-02909-xThe nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention (Source: Oncogene)
Source: Oncogene - December 11, 2023 Category: Cancer & Oncology Authors: Yang Lyu Fuda Xie Bonan Chen Wing Sum Shin Wei Chen Yulong He Kam Tong Leung Gary M. K. Tse Jun Yu Ka Fai To Wei Kang Source Type: research
ROS production by mitochondria: function or dysfunction?
Oncogene, Published online: 11 December 2023; doi:10.1038/s41388-023-02907-zROS production by mitochondria: function or dysfunction? (Source: Oncogene)
Source: Oncogene - December 11, 2023 Category: Cancer & Oncology Authors: Flavio R. Palma Benjamin N. Gantner Marcelo J. Sakiyama Cezar Kayzuka Sanjeev Shukla Riccardo Lacchini Brian Cunniff Marcelo G. Bonini Source Type: research
Correction: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
Oncogene, Published online: 11 December 2023; doi:10.1038/s41388-023-02916-yCorrection: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells (Source: Oncogene)
Source: Oncogene - December 11, 2023 Category: Cancer & Oncology Authors: Shoumin Zhu Mohammed Soutto Zheng Chen M. Blanca Piazuelo M. Kay Washington Abbes Belkhiri Alexander Zaika Dunfa Peng Wael El-Rifai Source Type: research
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
Oncogene, Published online: 08 December 2023; doi:10.1038/s41388-023-02900-6ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma (Source: Oncogene)
Source: Oncogene - December 8, 2023 Category: Cancer & Oncology Authors: Kasturee Jagirdar Marie E. Portuallo Meihan Wei Matthew Wilhide Jeremy A. Bravo Narula Bailey M. Robertson Gretchen M. Alicea Crystal Aguh Min Xiao Tetiana Godok Dylan Fingerman Gregory Schuyler Brown Meenhard Herlyn Vissy M. Elad Xinyu Guo Eneda Toska Da Source Type: research
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression
Oncogene, Published online: 04 December 2023; doi:10.1038/s41388-023-02897-yMYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression (Source: Oncogene)
Source: Oncogene - December 4, 2023 Category: Cancer & Oncology Authors: Alice Salib Nisitha Jayatilleke Janith A. Seneviratne Chelsea Mayoh Katleen De Preter Frank Speleman Belamy B. Cheung Daniel R. Carter Glenn M. Marshall Source Type: research
FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis
Oncogene, Published online: 04 December 2023; doi:10.1038/s41388-023-02906-0FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis (Source: Oncogene)
Source: Oncogene - December 4, 2023 Category: Cancer & Oncology Authors: Wenbo Sun Hengyuan Kou Yao Fang Fan Xu Zhi Xu Xiumei Wang Rong Yin Qin Zhang Qin Jiang Yong Xu Source Type: research
Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho
Oncogene, Published online: 01 December 2023; doi:10.1038/s41388-023-02904-2Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho (Source: Oncogene)
Source: Oncogene - December 1, 2023 Category: Cancer & Oncology Authors: Marana Abboud Keren Merenbakh-Lamin Hadas Volkov Shira Ben-Neriah Hagai Ligumsky Sarai Bronfeld Noa Keren-Khadmy Moshe Giladi Noam Shomron Ido Wolf Tami Rubinek Source Type: research
M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma
Oncogene, Published online: 01 December 2023; doi:10.1038/s41388-023-02882-5M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma (Source: Oncogene)
Source: Oncogene - December 1, 2023 Category: Cancer & Oncology Authors: Mingyu He Yang Wang Jiajie Xie Jiaying Pu Zhihua Shen Ao Wang Tao Li Tong Wang Guanghui Li Ying Liu Zhongting Mei Zijing Ren Wenbo Wang Xiaoyan Liu Jinhuan Hong Qian Liu Hong Lei Xiaoqi He Weijie Du Ye Yuan Lei Yang Source Type: research
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
Oncogene, Published online: 01 December 2023; doi:10.1038/s41388-023-02902-4RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4 (Source: Oncogene)
Source: Oncogene - December 1, 2023 Category: Cancer & Oncology Authors: Chun Wang Zhihang Chen Yun Yi Yang Ding Fei Xu Hui Kang Kun Lin Xiawen Shu Zibiao Zhong Zhonglin Zhang Jing Liu Zhong Xu Lan Liu Xingxing He Ying Chang Qiu Zhao Source Type: research
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia
Oncogene, Published online: 29 November 2023; doi:10.1038/s41388-023-02903-3The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia (Source: Oncogene)
Source: Oncogene - November 29, 2023 Category: Cancer & Oncology Authors: Estelle Erkner Thomas Hentrich Rebekka Schairer Rahel Fitzel Kathy-Ann Secker-Grob Johan Jeong Hildegard Keppeler Fulya Korkmaz Julia M. Schulze-Hentrich Claudia Lengerke Dominik Schneidawind Corina Schneidawind Source Type: research
Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer
Oncogene, Published online: 29 November 2023; doi:10.1038/s41388-023-02893-2Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer (Source: Oncogene)
Source: Oncogene - November 29, 2023 Category: Cancer & Oncology Authors: Feng Lyu Kerui Wu Shih-Ying Wu Ravindra Pramod Deshpande Abhishek Tyagi Isabella Ruiz Sindhu Yalavarthi Kounosuke Watabe Source Type: research
